Finance

Beta
Lists
1952:HKG
Everest Medicines Ltd
HK$28.76
-0.96%
(-0.28) 1D
Jun 5, 4:09:10 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1952...
Open
HK$29.54
High
HK$29.88
Low
HK$28.34
Mkt. cap
10.35B
Avg. vol.
3.00M
Volume
5.34M
52-wk high
HK$77.55
52-wk low
HK$28.10
EPS
-HK$1.03
No. of employees
812
Open
HK$29.54
High
HK$29.88
Low
HK$28.34
Mkt. cap
10.35B
Avg. vol.
3.00M
Volume
5.34M
52-wk high
HK$77.55
52-wk low
HK$28.10
EPS
-HK$1.03
No. of employees
812
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to 1952 in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for 1952 in the last 3 months.
Highest
Current HK$28.76
HK$84.00 (+192.07%)
Average
HK$69.50 (+141.66%)
Lowest
HK$55.00 (+91.24%)
News stories
From sources across the web
About Everest Medicines Ltd
CEOKerry Blanchard
Employees812
Founded2017
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
223.06M
223.06M
630.28M
630.28M
Cost of goods sold
73.36M
73.36M
189.05M
189.05M
Cost of revenue
73.36M
73.36M
189.05M
189.05M
Research and development expenses
97.61M
97.61M
157.91M
157.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
212.77M
212.77M
315.76M
315.76M
Operating expense
288.08M
288.08M
474.80M
474.80M
Total operating expenses
361.44M
361.44M
663.84M
663.84M
Operating income
-138.38M
-138.38M
-33.56M
-33.56M
Other non operating income
-
-
13.10M
13.10M
EBT including unusual items
-124.90M
-124.90M
-174.29M
-174.29M
EBT excluding unusual items
-126.58M
-126.58M
-914.50K
-914.50K
Income tax expense
-
-
-150.30M
-150.30M
Effective tax rate
-
-
86.24%
86.24%
Other operating expenses
-22.30M
-22.30M
1.13M
1.13M
Net income
-124.90M
-124.90M
-23.99M
-23.99M
Net profit margin
-55.99%
-55.99%
-3.81%
-3.81%
Earnings per share
-
-
-
-
Interest and investment income
12.12M
12.12M
45.88M
45.88M
Interest expense
-5.74M
-5.74M
-5.90M
-5.90M
Net interest expenses
6.38M
6.38M
39.98M
39.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
-104.83M
-104.83M
-762.00K
-762.00K
Gain or loss from assets sale
16.00K
16.00K
500.00
500.00
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more